Researchers at a Dutch University have developed a compound (cAMP analog) that helps protect kidneys from ischemic damage prior to transplantation. The University is looking for a license agreement with a biotech/pharmaceutical company or a developer of anti-cancer drug delivery system with expertise in the field of cancers, renal disorders or transplantations.